Insider filing · GH
Chris Freeman
Chief Commercial Officer
profile →
Guardant Health, Inc.
GH · Healthcare · 58 filings in 24 months
ticker →
Chris Freeman sold $3.0M of Guardant Health (GH)
Executed Dec 5 2025, disclosed Dec 8 2025, 3 days later.
Value, as filed
$3.0M
28,986 sh across 5 lots
Executed
Dec 5 2025
the trade date, as filed
Disclosed
Dec 8 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CFChris Freeman (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Guardant Health, Inc. (GH). The largest single filing was $10.8M of GH (63,605 sh across 4 lots, as filed), executed Aug 10.
The name
GHHealthcare · Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Chris Freeman in GH
GHSALE
Guardant Health, Inc.
$10.8M63,605 sh across 4 lots
Exec Aug 10
Filed Aug 11 · 6:22 PM ET GHSALE Guardant Health, Inc. $2.9M
24,406 sh × $118.67
Exec May 22
Filed May 26 · 5:30 PM ET